SteadyMed Ltd. et al. vs. United Therapeutics Corporation
Explore the PTAB proceeding IPR2016-00006 filed by SteadyMed Ltd. et al. on 2015-10-02. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-00006
Filing Date
2015-10-02
Accorded Filing Date
2015-10-02
Institution Decision Date
2016-04-08
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2017-03-31
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
SteadyMed Ltd. et al.
Represented By
Pollack, Stuartet alPatent Owner / Respondent
United Therapeutics Corporation
Represented By
Maebius, Stephenet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34702 | Andrew Rawlins | +1 202-672-5349 |
| 35264 | Stephen Maebius | +1 202-672-5569 |
| 37288 | Courtenay Brinckerhoff | +1 202-672-5300 |
| 47358 | Andrew Mitchell | +1 414-297-5722 |
| 55600 | Kristel Schorr | +1 202-672-5300 |
| 56439 | Alexey Saprigin | +1 202-295-4632 |
| 59349 | Benjamin Berkowitz | +1 202-672-5300 |
| 59987 | Shaun Snader | +1 -- |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,497,393 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,748,657 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,156,786 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,604,901 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,593,066 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,548,863 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,478,410 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,322,099 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,723,887 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2023033831 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 1,423,207 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,242,305 B2 | US Continuation / Sibling | View Official Patent → |
Liquidia Technologies, Inc. v. United Therapeutics Corp.
Liquidia Technolgies, Inc. v. United Therapeutics Corp.